Sweet Syndrome Following SARS-CoV2 Vaccination

Sweet Syndrome Following SARS-CoV2 Vaccination

Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-y...

Full description

Bibliographic Details
Main Authors: Maria Efenesia Baffa, Roberto Maglie, Neri Giovannozzi, Francesca Montefusco, Stefano Senatore, Daniela Massi, Emiliano Antiga
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Vaccines
Subjects:
Sweet’s syndrome
mRNA vaccines
neutrophilic dermatoses
adverse event
Online Access:https://www.mdpi.com/2076-393X/9/11/1212

Internet

https://www.mdpi.com/2076-393X/9/11/1212

Similar Items